A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Buller, Harry R. ; Lensing, Anthonie W.A. ; Prins, Martin H. ; Agnelli, Giancarlo ; Cohen, Alexander ; Gallus, Alexander S. ; Misselwitz, Frank ; Raskob, Gary ; Schellong, Sebastian ; Segers, Annelise

Blood, 2008-09, Vol.112 (6), p.2242-2247 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível